Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Stock Screener   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in
 
Register now or login to post to this thread.

Craneware plc (CRW)     

dreamcatcher - 04 Sep 2012 16:49

http://www.craneware.com/

Craneware, Inc. is a leading supplier of business intelligence and revenue cycle software that provides clients with chargemaster management software and products designed to optimize legitimate reimbursements and assist in managing the revenue cycle through better information, workflow, pricing strategy, capture of lost revenue and best practice modeling. Our innovative and scalable products are designed to ensure that you have the information you need to succeed in healthcare financial management.

A talented mix of employees from the healthcare industry, software engineering, business consulting, customer support and training provide the perfect blend for providing extremely powerful solutions to problems faced by hospital's financial teams.

Our consultant's years of experience in the healthcare industry are the vital source of financial, clinical and coding expertise that together with talented software developers combine to make our products so effective.

Our dedicated support team work hard at ensuring our customers always come first and pride themselves on exemplary service throughout the relationship from first install to advanced user training. Installation times are in weeks instead of months, Support responses are in minutes instead of days.

Headquartered in Scotland with offices across the US, Craneware delivers unparalleled solutions to the problems facing healthcare financial managers every day.


free counters
Chart.aspx?Provider=EODIntra&Code=CRW&SiChart.aspx?Provider=EODIntra&Code=CRW&Si

dreamcatcher - 04 Sep 2012 17:11 - 2 of 86

Craneware shares up as unveils 'solid' results


http://www.proactiveinvestors.co.uk/companies/news/47664/craneware-shares-up-as-unveils-solid-results-47664.html

dreamcatcher - 05 Sep 2012 15:20 - 3 of 86

Up 7%today recovering well

dreamcatcher - 05 Sep 2012 16:34 - 4 of 86

UP over 10% today

dreamcatcher - 07 Sep 2012 16:40 - 5 of 86

Another good day

dreamcatcher - 08 Sep 2012 12:45 - 6 of 86

Still rated a buy in this weeks IC.'' The shares bounced on these results although they are still downroughly 40 per cent since last october.Adjust for the cashpile and the shares now trade 14 times forecast earnings - which isn't so pricey given the impressive growth prospects''.

dreamcatcher - 20 Sep 2012 08:36 - 7 of 86

:-))

dreamcatcher - 25 Sep 2012 15:39 - 8 of 86

Flying up in Sept.

dreamcatcher - 03 Nov 2012 08:49 - 9 of 86

Ex divi 9th Nov ---- divi 5.7p payed on 7th Dec

dreamcatcher - 08 Nov 2012 08:14 - 10 of 86

Craneware chief predicts return to historic revenue growth
Wed 1:28 pm by Ian LyallIts business in outline is a very simple one. It provides the software that ensures American hospitals bill for their services correctly and can deal with an increasing amount of audits

With investors given to almost bi-polar mood swings, the smallest disappointment can lead to an almost disproportionate response.

Keith Neilson, chief executive of Craneware (LON:CRW), whose software is used in around a quarter of American hospitals, has witnessed this at close quarters.

At the moment he is enjoying the upsurge in the company’s fortunes, with stock rising (it has put on 56% since the middle of August), the outlook is improving, and one of the company’s main competitors is in retreat.

What a contrast with the early portion of 2012, which saw the stock knocked from pillar to post after a first profits warning since listing in 2007.

The slip-up was the result of a “perfect storm” of a lost contract and a slowdown in the US market as the healthcare system dealt with the introduction of electronic records.

The challenge for Neilson and his team has been convincing the market it is over the hump and Craneware is ready to return to its previous growth trajectory.

The strong rally of the share price suggests the message is finally starting to get through after some initial fears the electronic records hiatus was yet to fully run its course.

A share price of 436 pence still places the company on a forward price-to-earnings multiple of 13-14 times when it has traditionally traded in the low 20s.

Getting Craneware back to these levels will rely on management capitalising on some large potential opportunities in the space.

Its business in outline is a very simple one. It provides the software that ensures American hospitals bill for their services correctly and can deal with an increasing amount of audits.

That might sound fairly straightforward, but the US system is as complicated as it is dysfunctional.

Since IPO, the group has doubled its market share to 25 per cent, which helped it generate revenues of $41 million last financial year and profits of almost $12 million.

Over 80 per cent of its sales are recurring. The company is paid upfront each year and contracts tend to run for five years at a time, which gives it a lot of forward visibility.

Craneware is currently renewing existing customers at a rate of 109 per cent of the value of the original, which suggests it has been able to squeeze through price rises.

The hiccup this year has meant that top line growth was a comparatively pedestrian 8 per cent.

Neilson is predicting it will return to historic levels of ‘high teens, or early 20s’ per cent growth.

There is a potentially huge market opportunity in the order of US$1.5-US$2bn, he adds, that could come from growing its market share, selling more products and data to customers.

Currently, hospitals take an average of 1.6 products from a suite of nine.

There is also the opportunity to sell online to those businesses not already taking its software, Neilson suggests.

Of course the company will be going aggressively for market share as its leading competitor in the space looks to be beating a retreat from the sector.

The data that its software is able to generate will also be an increasing source of new revenues as health system and practitioners, under huge potential pressure and the weight of an ageing population, look to work smarter.

“Because of the data we are gathering the opportunities to diversify what we do organically by providing content back to hospitals and big pharma are really huge for us,” says Neilson.

“We could be looking to sell content and data plays - whether that is benchmarking, or looking at the efficacy of drugs.

“There is real ‘stick-ability’ of the software play now. But there is real longevity in the way we want to take the company.”

With around $29 million in the bank, the group is well capitalised.

It begs the question as to what Craneware might do with this cash pile – return it to shareholders, invest it or spend the money on an acquisition?

“We have been asked if we are going to return cash in future,” says Neilson.

“And the answer is possibly, yes. We continue to grow cash, we are cash generative.

“But equally we have to ensure we can take advantage of any opportunities out there in the marketplace.

“We are dealing with large enterprises signing up for five plus years.

“And they want to see we have the financial strength and prudence to do that.”

Pressed on the potential of making an acquisition, the Craneware CEO sounds a note of caution.

“If we’d been speaking a year ago when we had four or five products our priorities then would be product portfolio, market share and domain expertise,” he explains.

“That has probably reversed in the last year as we now have quite a broad suite.

“Now what we need to do is continue with domain expertise and the market share piece.

“As you know acquisitions never come along when you want them. So never say never.”

City broker Investec acknowledges that the recently published prelims told the story of a year marred by disruption.

However, analyst James Goodman also reckons the financial performance was still reasonably solid, which he says is testament to Craneware’s robust business model.

“Commentary around the underlying core market improving (month-on-month sales growth since January) and a better explanation of large, contractual opportunities have helped the shares move higher,” Goodman adds.

“But they remain cheap given their underlying quality and the market opportunity.”

dreamcatcher - 08 Nov 2012 08:16 - 11 of 86

RNS Number : 6294Q

Craneware plc

08 November 2012








Craneware plc

("Craneware" or the "Company")



AGM Statement



8 November 2012 - Craneware(AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, will be holding its Annual General Meeting at 10am today at the Company's headquarters in Edinburgh, Scotland. At the meeting Keith Neilson, CEO of the Company, will make the following statement:



"Fiscal and regulatory pressures on US hospitals continue to drive interest in our suite of software solutions. Sales activity continues to build, which combined with our increased market presence, strong pipeline and high levels of revenue visibility give us confidence in achieving a successful year and beyond."

dreamcatcher - 08 Nov 2012 11:02 - 12 of 86

Craneware shares climb ahead of AGM
9:35 am by Ian LyallCraneware provides the software that ensures American hospitals bill for their services correctly and can deal with an increasing amount of audits



Software specialist Craneware’s (LON:CRW) shares spiked 7% in early deals ahead of what is likely to be an upbeat statement from the company’s chief executive at the annual meeting.

Keith Neilson will tell attendees in Edinburgh: “Fiscal and regulatory pressures on US hospitals continue to drive interest in our suite of software solutions.

“Sales activity continues to build, which combined with our increased market presence, strong pipeline and high levels of revenue visibility give us confidence in achieving a successful year and beyond.”

Craneware provides the software that ensures American hospitals bill for their services correctly and can deal with an increasing amount of audits.

That might sound fairly straightforward, but the US system is as complicated as it is dysfunctional.

Since IPO, the group has doubled its market share to 25%, which helped it generate revenues of $41 million last financial year and profits of almost $12 million.

Over 80% of its sales are recurring. The company is paid upfront each year and contracts tend to run for five years at a time, which gives it a lot of forward visibility.

Craneware is currently renewing existing customers at a rate of 109% of the value of the original, which suggests it has been able to squeeze through price rises.

However a slowdown earlier this year meant that top line growth was a comparatively pedestrian 8%.

In an interview with Proactive Investors earlier this week, Neilson predicted a return to historic growth levels of ‘high teens, or early 20s’ per cent.

The response to Neilson’s comments ahead of today’s meeting pushed the shares 30 pence higher to 456 pence.

In the last three months they have advanced 66%.

dreamcatcher - 08 Nov 2012 18:07 - 13 of 86

Craneware sales activity continues to build
StockMarketWire.com
Craneware's sales activity continues to build, which combined with its increased market presence, strong pipeline and high levels of revenue visibility gives it confidence in achieving a successful year and beyond.

At 10:00am: (LON:CRW) share price was +22.5p at 448.5p



Story provided by StockMarketWire.com

dreamcatcher - 08 Nov 2012 18:07 - 14 of 86

Result of AGM
RNS
RNS Number : 6596Q
Craneware plc
08 November 2012







Craneware plc

("Craneware" or the "Company")



Result of AGM



8 November 2012 - Craneware (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, announces that all resolutions put to shareholders at the Company's AGM held today were duly passed.

dreamcatcher - 09 Nov 2012 07:05 - 15 of 86

Dividend Currency Election
RNS
RNS Number : 7121Q
Craneware plc
09 November 2012







Craneware plc

("Craneware" or the "Company")



Dividend Currency Election



9 November 2012 - Craneware (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, today gives further information regarding its final dividend announced on 4 September 2012.



For those shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, or who register to do so by the close of business on 9 November 2012, the dividend will be paid at an exchange rate of $1.598/£1.

dreamcatcher - 19 Nov 2012 16:03 - 16 of 86

Craneware: Investec raises target price from 410p to 475p and downgrades from buy to hold.

dreamcatcher - 19 Nov 2012 20:09 - 17 of 86

Craneware downgraded by Investec

Investec has downgraded its recommendation on Healthcare software company Craneware [LON:CRW] to ‘hold’ from ‘buy’ as the shares are now considered to be fairly valued after their recent strong run.

The City broker has increased its share price target by 16 per cent to 475 pence from 410 pence.

Analyst James Goodman commented: “Craneware shares have had a tremendous run, up 70% in three months.

“We continue to see Craneware as an exciting and high-quality investment proposition in an attractive structural growth market.

“However, we believe Craneware is now trading at fair value, ahead of more material evidence of a return to positive forecast momentum.

“With the recent annual general meeting statement having provided a level of further comfort we move our target price to 475 pence (from 410 pence), but our recommendation to hold (from buy).”

At 11:45 am shares in Craneware were up 0.25 pence at 476 pence.

dreamcatcher - 14 Dec 2012 16:47 - 18 of 86

Sp drop of over 7% on 12,000 shares sold ?

dreamcatcher - 21 Jan 2013 07:10 - 19 of 86

Trading Update
RNS
RNS Number : 9376V
Craneware plc
21 January 2013







Craneware plc

("Craneware" or the "Company")



Trading Update



21 January 2013 - Craneware(AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, provides an update on trading for the six month period ended 31 December 2012.



Trading has been positive in the first half of the financial year and the Company expects to report revenue growth to $20.1m (H112: $18.8m) with further growth at the adjusted EBITDA level of approximately 15% in comparison to the same period in the prior year (H112: $4.65m). This performance is in line with management's expectations, delivering similar first half to second half expectation splits as those seen in the previous financial year.



Keith Neilson, CEO of Craneware,commented, "The increased levels of sales activity discussed at the time of our final results in September 2012 have begun to contribute to revenue growth. Fiscal and regulatory pressures on US hospitals, including the recently announced expansion of the Medicare Recovery Audit Contractor Program, continues to drive interest in our suite of software solutions and we are confident in the ongoing strength of our position within this growing area of the US healthcare market."



Craneware will be announcing its Interim Results on 26 February 2013

dreamcatcher - 21 Jan 2013 08:24 - 20 of 86

Revenue growth continues at Craneware
Mon 21 Jan 2013

CRW - Craneware

Latest Prices
Name Price %
Craneware 387.50p 0.00%

FTSE AIM 100 3,303 +0.05%
FTSE AIM All-Share 739 +0.07%
Software & Computer Services 982 +0.06%

LONDON (SHARECAST) - US healthcare software developer Craneware said first half trading has been positive as increased levels of sales start to contribute to revenue growth.

The group, which provides monitoring and automated revenue systems, said it expects to report revenue growth to $20.1m, up from $18.8m in the same half in 2012 with further growth at the adjusted EBITDA level of around 15% from the same period last year.

Craneware said this performance is in line with management's expectations, "delivering similar first half to second half expectation splits as those seen in the previous financial year."

CEO Keith Neilson commented, "The increased levels of sales activity discussed at the time of our final results in September 2012 have begun to contribute to revenue growth."

"Fiscal and regulatory pressures on US hospitals, including the recently announced expansion of the Medicare Recovery Audit Contractor Programme, continues to drive interest in our suite of software solutions and we are confident in the ongoing strength of our position within this growing area of the US healthcare market."

dreamcatcher - 21 Jan 2013 09:38 - 21 of 86

Craneware: Investec moves target price from 475p to 410p and stays with its hold rating.
Register now or login to post to this thread.